Sangamo BioSciences (SGMO) Reiterated at Hold by Stifel, New Data Not Thesis Changing, Looking For Successful ERT Withdrawal Going Forward
Tweet Send to a Friend
Stifel analyst Benjamin Burnett reiterated a Hold rating and $6.00 price target on Sangamo BioSciences (NASDAQ: SGMO), following recently presented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
